4 ms·
The full article title is "A Vaccine for Depression?: Ketamine's effect holsters a new theory of mental illness." I have mixed feelings about posts being requ
by escape_goat 11y ago
The full article title is "A Vaccine for Depression?: Ketamine's effect holsters a new theory of mental illness." I have mixed feelings about posts being required to suffer from the title, as this is often an editorial rather than an authorial decision, but the submerged gist of the article, the novel content, is indeed the suggestion that Ketamine could be used as a "vaccine" for post-traumatic stress disorder.
A few words about new theories. All new theories that can garner such enthusiasm for their presentation are invariably bolstered by something. No-one writes magazine articles about ambiguous signals from an exciting new theory. If the evidence presented is not in some way definitive, then it should be viewed as a precondition for the propagation of the theory, not evidence in favour of it. Few of us are expert judges of neurological theories, and we are not able to tell if there is anything substantial beyond the feeling that we experience that something valuable has been learned.
I know that the effects of Ketamine in treating serious episodic depression are very exciting. I feel that I understand enough to suggest that neuroplasticity is not an especially 'new' theory, or a 'theory' by itself. The neuroplastic response is real, well documented, and undisputed. What is a theory, and had not been established as fact, the last time I discussed it with someone, is that idea that the neuroplastic response is the central intermediary between the physical effect of the drug and the clinical effect of the drug. It occurs, but it had not been established that it is causal.
The central suggestion regarding the 'vaccine' effect seemed to be buried a bit in the article (unless I missed something in skimming), but it is the actual new information, which is interesting and heartening. Soldiers coming to a forward operating medical station with severe burns were treated with Ketamine rather than another anaesthetic because of its relative safety. They subsequently developed PTSD half as often as all soldiers and civilians treated for less or equally severe burns with other anaesthetics.
On the basis of the theory that PTSD and depression emerge an erosion of neurosynaptic connections, the leap is made from there to the idea that Ketamine might perhaps serve as a true 'vaccine' when people were going into high-stress situations. From my relatively uneducated perspective, this seems a bit irresponsible in two separate ways.
Firstly, the evidence is that the soldiers were 'vaccinated' against psychological disturbances associated with extreme trauma... after the initial extreme trauma had occurred. There is evidence from studies with mice that a Ketamine treatment changes their response to stressors in a way that seems both dramatic and positive. Ketamine is a common recreational drug. If we should be excited about the prospect of this response being replicated in humans, then why is there not already ample evidence that this response is replicated in humans?
Secondly, there is absolutely no reason that we should conclude that the effect of the Ketamine on the burn victims has anything to do with neuroplastic response. Ketamine is an anesthetic. It limits pain, which is traumatic. Anesthetics operate in different ways. Ketamine seems to inhibit the transmission of pain signals in the spinal cord. This prevents them from reaching the limbic system. Other forms of anesthesia may not. Ketamine is, infamously, an amnesic and a dissociative. Stress disorders require memory formation. Ketamine prevents memory formation. Other forms of anesthesia may not. And so on. In the context of the surfeit of plausible explanations for this effect, to suggest that the effect is particular evidence supporting a theory that PTSD is cured by neuroplastic regeneration of synaptic connections is not particularly responsible. It might not be terrible journalism, but it is definitely bad science, and almost certainly not something that was presented as science to the journalist.
- drharvey 11y ago"The central suggestion regarding the 'vaccine' effect seemed to be buried a bit in the article (unless I missed something in skimming), but it is the actual new information, which is interesting and heartening." You are correct, this is a new finding. It does not, however, come from the study looking at soldiers. In that study, ketamine was actually given after stress (not as a 'vaccine'). Those researchers also failed to replicate that effect when they looked a larger group of soldiers. The first study was done in 2008 and the second one was done in 2014. Believe me, if they had found a protective effect in humans 7 years ago, you would have heard about it by now. The research that actually shows the ketamine might be a 'vaccine' has all come out this year (2015). And, so far, it's all only in mice. The scientific publication referred to in the Nautilus article is "Ketamine as a Prophylactic Against Stress-Induced Depressive-Like Behavior": http://www.biologicalpsychiatryjournal.com/article/S0006-3223(15)00360-1/abstract http://www.biologicalpsychiatryjournal.com/article/S0006-322.... At least two other research teams at other universities (FSU & UC-Boulder) have independently also found similar effects, but none of that is published yet (though it was presented this year at the national Society for Neuroscience conference). In other words: yes, it's new. Additionally, neuroscientists at Mt. Sinai, the NIMH, and UC-Boulder (among others) have found that bacteria and immune cells might also be used to 'vaccinate' against stress. Again, most of that research--though not all of it--is still not published yet, and has only been presented at conferences so far.
- drharvey 11y ago-- As an aside, it's a textbook example of multiple discovery/simultaneous invention: https://en.wikipedia.org/wiki/Multiple_discovery https://en.wikipedia.org/wiki/Multiple_discovery -- I also completely agree that the sedative-level dose given to soldiers after stress might have worked by blocking traumatic memory formation. It has already been established that blocking or "erasing" stress memories may prevent PTSD (here's just one example: http://www.medscape.com/viewarticle/819452 http://www.medscape.com/viewarticle/819452). In the studies in mice, ketamine was no longer in the animals' systems by the time they were stressed. So they were not sedated. And the researchers tested memory formation to confirm it was not affected. Thus, it seems that ketamine's protective effect in mice isn't just because memory is disrupted. That said, it is always possible they missed something. From what I can find, it doesn't seem like anyone has even looked yet to see how this ketamine-vaccine strategy effects neuroplasticity. At this stage, it's probably best to consider the post-stress effect of ketamine in soldiers (1), the pre-stress protection in mice (2), and the neuroplastic effects of ketamine (3) as three separate things.